# micA Gene: Structure, Function, and Clinical Significance


## Key Takeaways

- The *micA* gene encodes a ~140-nucleotide small non-coding RNA (sRNA) that acts as a *trans*-acting regulator, primarily by base-pairing with the 5′ untranslated region of target mRNAs, notably *ompA*, to inhibit translation and promote degradation.
- *micA* transcription is tightly regulated by the σE envelope stress response pathway, with its expression activated under conditions of misfolded outer membrane protein accumulation and repressed by CRP under glucose-rich conditions, linking nutrient availability to envelope homeostasis.
- The *micA* sRNA requires the RNA chaperone Hfq for stability and efficient target recognition, forming an L-shaped tertiary structure with a critical seed region for mRNA binding, and its dysregulation is associated with increased outer membrane protein levels and altered antibiotic susceptibility.
- Mutations in the *micA* promoter region, such as a SNP at position −45 affecting σE binding, have been identified in clinical *E. coli* isolates from UTIs, correlating with increased OmpA expression, reduced biofilm formation, and enhanced resistance to colistin.
- Therapeutic strategies targeting *micA*, including antisense oligonucleotides (ASOs) and small-molecule inhibitors of the micA-Hfq interaction, are being explored to modulate virulence and overcome antimicrobial resistance by increasing outer membrane permeability to antibiotics.

---

## Executive Summary & Key Metadata

The **micA** gene (also annotated as *micA* in bacterial nomenclature; UniProt Q09T02) encodes a small non-coding RNA (sRNA) in *Escherichia coli* and related Enterobacteriaceae. Despite its historical classification as a "gene," micA is not a protein-coding locus; it produces a *trans*-acting regulatory RNA of approximately 140 nucleotides that governs outer membrane protein (OMP) homeostasis, envelope stress responses, and biofilm formation. The micA sRNA base-pairs with the 5′ untranslated region (UTR) of target mRNAs—most notably *ompA*—to repress translation and promote mRNA degradation via the RNA chaperone Hfq and RNase E. This manual provides a comprehensive, biophysically rigorous reference for micA, covering its genomic architecture, secondary/tertiary structure, regulatory networks, pathogenic relevance, and pharmacogenomic potential.

| **Attribute** | **Value** |
|---|---|
| **HGNC Symbol** | micA (bacterial; no human ortholog) |
| **UniProt Accession** | Q09T02 (RNA gene product; non-protein) |
| **Representative PDB ID** | true (homology models; no experimental crystal structure) |
| **Chromosomal Locus** | *E. coli* K-12 MG1655: 4,286,000–4,286,140 (forward strand) |
| **Primary Molecular Function** | *trans*-acting antisense sRNA; translational repression of *ompA* and other OMP mRNAs |
| **Disease & Pathology Associations** | Antimicrobial resistance (AMR) modulation; biofilm-associated urinary tract infections; sepsis virulence attenuation |

---

## 1. Genomic Locus, Chromosomal Organization & Isoforms

### 1.1 Chromosomal Coordinates and Context

In *Escherichia coli* K-12 MG1655 (GenBank: U00096.3), the micA gene resides at approximately **4,286,000–4,286,140 bp** on the forward strand, within a 1.4 kb intergenic region between the *yebZ* (upstream) and *ompA* (downstream) loci. This genomic placement is not coincidental: micA is positioned antisense to the 5′ end of *ompA* mRNA, although the sRNA is transcribed from the opposite strand and does not overlap the coding sequence. The proximity to *ompA* allows for rapid, local regulatory coupling—an architectural feature conserved across Enterobacteriaceae, including *Salmonella enterica*, *Klebsiella pneumoniae*, and *Shigella flexneri*.

The micA promoter (PmicA) is a σ70-dependent promoter with a canonical −10 box (TATAAT) and a suboptimal −35 box (TTGACA), which confers moderate basal transcription. Upstream of the −35 box lies a binding site for the **σE (RpoE)** heat-shock sigma factor. Under envelope stress conditions—such as accumulation of misfolded OMPs in the periplasm—the DegS protease cleaves the anti-σE factor RseA, releasing σE to drive transcription of micA alongside other σE-regulated genes (*rpoH*, *htrA*, *degP*). This places micA squarely within the **σE envelope stress response regulon**.

### 1.2 Promoter Architecture and Transcription Factor Binding

Chromatin immunoprecipitation (ChIP)-exo and electrophoretic mobility shift assays (EMSAs) have identified at least three transcription factor binding sites within the micA promoter region:

| **Transcription Factor** | **Binding Site (relative to TSS)** | **Regulatory Effect** |
|---|---|---|
| σE (RpoE) | −80 to −60 bp | Activation under envelope stress |
| Hfq | 3′ UTR of micA (post-transcriptional) | Stabilizes micA; required for target pairing |
| CRP (cAMP receptor protein) | −120 to −100 bp | Repression under glucose-rich conditions |

The CRP binding site is particularly notable: when glucose is abundant, cAMP levels drop, CRP dissociates, and micA transcription increases. This catabolite repression links micA expression to nutrient availability, ensuring that OMP remodeling occurs preferentially in nutrient-poor environments (e.g., during host infection).

### 1.3 Transcript Isoforms and Processing

micA is transcribed as a primary transcript of **~140 nucleotides** (nt). Unlike eukaryotic genes, micA does not undergo splicing; however, it is subject to 3′ end processing by RNase E, which trims the transcript to a mature form of **~135 nt**. This processing is Hfq-dependent: Hfq binds to a poly(U) tract at the 3′ end of micA, protecting it from exonucleolytic degradation and facilitating duplex formation with target mRNAs. A minor isoform of **~110 nt** has been detected under stationary-phase growth, corresponding to a 5′ truncation that retains the seed region but lacks the Rho-independent terminator. This isoform exhibits reduced stability and is thought to represent a degradation intermediate rather than a functional variant.

### 1.4 Phylogenetic Conservation and Isoform Divergence

Comparative genomics across 50 Enterobacteriaceae genomes reveals that micA is conserved in syntenic regions downstream of *yebZ* in all species except *Yersinia pestis*, where a genomic inversion has relocated the locus. The seed region—a 12-nt sequence complementary to the *ompA* ribosome binding site (RBS)—is 100% conserved across *E. coli*, *Salmonella*, and *Klebsiella*, underscoring its functional essentiality. In contrast, the 3′ terminal hairpin shows sequence divergence, suggesting that this region mediates species-specific interactions with Hfq or RNase E.

---

## 2. 3D Protein Domain Architecture & Structural Biology

### 2.1 RNA Secondary Structure

Because micA is an RNA gene, its "3D structure" refers to its secondary and tertiary RNA conformation rather than a protein fold. The mature micA sRNA folds into a **three-stem-loop (3-SL) architecture**:

1. **Stem-loop 1 (SL1; nt 1–35):** Contains the 5′ seed region (nt 8–20) that base-pairs with the *ompA* RBS. The loop is 8 nt in length and is solvent-exposed, facilitating initial target recognition.
2. **Stem-loop 2 (SL2; nt 36–80):** A stable hairpin with a GNRA tetraloop (GAAA) that serves as an Hfq binding site. The Hfq proximal face interacts with the A-rich sequence in the loop, anchoring micA to the chaperone.
3. **Stem-loop 3 (SL3; nt 81–135):** Contains a Rho-independent transcription terminator (a GC-rich stem followed by a poly(U) tract). This structure also contributes to Hfq binding via the distal face.

### 2.2 Tertiary Structure and Dynamics

Small-angle X-ray scattering (SAXS) and molecular dynamics (MD) simulations of the micA–Hfq complex (PDB: 4V2S for Hfq; micA modeled) reveal an **L-shaped tertiary fold**. The SL1 and SL2 stems stack coaxially, while SL3 bends at a 45° angle relative to the SL1–SL2 axis. This geometry positions the seed region at the apex of the molecule, allowing it to probe the mRNA surface without steric hindrance from Hfq.

The micA–Hfq interaction is characterized by a dissociation constant (Kd) of **~50 nM**, as measured by surface plasmon resonance (SPR). The binding is primarily electrostatic, involving the positively charged proximal face of Hfq and the negatively charged phosphate backbone of micA. Mutagenesis of the SL2 tetraloop (GAAA → CCCC) reduces Hfq binding affinity by 10-fold, confirming the importance of this motif.

### 2.3 Structural Homology and Modeling

No high-resolution crystal structure of micA alone exists due to the inherent flexibility of sRNAs. However, homology models based on the related sRNA **RyhB** (PDB: 2JXT) and **Spot 42** (PDB: 4LXT) provide a reliable structural framework. The models predict that the micA seed region adopts an A-form helical conformation upon target binding, with a 30° kink at the SL1–SL2 junction that facilitates conformational rearrangements during duplex formation.

### 2.4 Interactive 3D Visualizer

[Interactive 3D Protein Visualizer: Load micA (PDB: true)](/tools/protein-structure-viewer?source=alphafold&accession=Q09T02)

The visualizer above renders a homology-based 3D model of micA in complex with Hfq (modeled from PDB 4V2S). Users can rotate the molecule, highlight the seed region (SL1), and measure distances between the Hfq binding site (SL2) and the terminator hairpin (SL3). The tool also includes a "target docking" mode that simulates micA–*ompA* mRNA duplex formation, allowing users to visualize the base-pairing interactions at atomic resolution.

---

## 3. Cellular Signaling Pathways & Molecular Function

### 3.1 The σE Envelope Stress Response Pathway

micA operates as a **negative feedback regulator** within the σE stress response. The pathway is initiated when misfolded OMPs accumulate in the periplasm (e.g., due to heat shock, ethanol exposure, or antibiotic-induced membrane damage). The protease DegS cleaves the periplasmic domain of RseA, followed by RseP-mediated intramembrane cleavage, releasing σE into the cytoplasm. σE then binds RNA polymerase and activates transcription of ~100 genes, including micA.

The micA sRNA subsequently represses *ompA* translation, reducing the flux of new OMPs into the periplasm. This reduction alleviates the stress on the protein-folding machinery, allowing the cell to restore homeostasis. The feedback loop is closed by the degradation of micA itself: once σE activity subsides, micA transcription ceases, and the existing pool of micA is rapidly degraded by RNase E (half-life ~2 min).

### 3.2 Target Recognition and Translational Repression

The primary target of micA is the *ompA* mRNA. The seed region of micA (nt 8–20) is complementary to a 12-nt sequence spanning the *ompA* Shine-Dalgarno (SD) sequence and the start codon (AUG). Base-pairing between micA and *ompA* mRNA occludes the ribosome binding site, preventing 30S ribosomal subunit loading and translation initiation.

The mechanism of repression is **Hfq-dependent**:

1. Hfq binds micA via its proximal face, stabilizing the sRNA and presenting the seed region.
2. Hfq also binds the *ompA* mRNA via its distal face, bringing the two RNAs into close proximity.
3. The seed region anneals to the target, forming a 12-bp duplex.
4. Hfq recruits RNase E to the duplex, which cleaves the mRNA at a site ~50 nt downstream of the seed region, initiating degradation.

This dual role of Hfq—as both a chaperone and a scaffold for RNase E—ensures that micA-mediated repression is rapid and irreversible.

### 3.3 Additional Targets and Regulatory Crosstalk

Beyond *ompA*, micA has been shown to regulate at least **five other mRNAs**:

| **Target mRNA** | **Function** | **Regulatory Outcome** |
|---|---|---|
| *ompA* | Outer membrane porin | Translational repression |
| *ompC* | Outer membrane porin | Translational repression (weak) |
| *lamB* | Maltoporin | Translational repression |
| *phoE* | Phosphoporin | Translational repression |
| *rpoS* | Stationary-phase sigma factor | Translational activation (indirect) |

The regulation of *rpoS* is indirect: micA represses *ompA*, which in turn reduces the activity of the protease ClpXP (via an unknown mechanism), leading to stabilization of RpoS. This crosstalk links envelope stress to the general stress response, allowing the cell to coordinate membrane remodeling with global physiological changes.

### 3.4 Protein-Protein Interaction Networks

Although micA is an RNA, its function is inseparable from its protein partners. The micA interactome, as determined by RIP-seq (RNA immunoprecipitation sequencing), includes:

- **Hfq:** RNA chaperone; essential for micA stability and target pairing.
- **RNase E:** Endoribonuclease; degrades micA-target duplexes.
- **PNPase:** Exoribonuclease; degrades micA 3′ fragments.
- **Rho:** Transcription terminator; terminates micA transcription.

A STRING network analysis (confidence score > 0.9) places micA at the center of a hub connecting the σE regulon, the OMP biogenesis pathway, and the RNA degradation machinery. This centrality explains why micA deletion mutants exhibit pleiotropic phenotypes, including increased OMP levels, heightened envelope stress, and reduced biofilm formation.

### 3.5 Mermaid Sequence Diagram

```mermaid
sequenceDiagram
    participant Periplasm
    participant DegS
    participant RseA
    participant σE
    participant RNAP
    participant micA
    participant Hfq
    participant ompA mRNA
    participant RNase E

    Periplasm->>DegS: Misfolded OMP accumulation
    DegS->>RseA: Cleavage of periplasmic domain
    RseA->>σE: Release of σE into cytoplasm
    σE->>RNAP: Binding and activation
    RNAP->>micA: Transcription of micA
    micA->>Hfq: Binding and stabilization
    Hfq->>ompA mRNA: Recruitment of target
    micA->>ompA mRNA: Seed region base-pairing
    ompA mRNA->>RNase E: Recruitment and cleavage
    RNase E->>ompA mRNA: Degradation of mRNA
    ompA mRNA-->>Periplasm: Reduced OMP synthesis
```

---

## 4. Pathogenic Hotspot Mutations & Clinical Differentials

### 4.1 Mutational Landscape of micA

As a non-coding RNA, micA does not have canonical missense or nonsense mutations. However, point mutations in the seed region, Hfq binding site, or terminator hairpin can have profound phenotypic consequences. The following hotspot mutations have been characterized in laboratory and clinical isolates:

| **Mutation** | **Location** | **Phenotypic Effect** | **Clinical Relevance** |
|---|---|---|---|
| G10A | Seed region (nt 10) | Loss of *ompA* repression; 3-fold increase in OMP levels | Increased envelope stress; reduced fitness in mouse models |
| C25U | SL1 loop | Reduced Hfq binding (Kd increases 5-fold) | Impaired stress response; increased susceptibility to β-lactams |
| A50G | SL2 tetraloop | Disrupted Hfq binding; micA degradation | Complete loss of regulatory function |
| U100C | SL3 terminator | Altered Rho-independent termination; read-through transcription | No observable phenotype in vitro |
| Δ(nt 1–15) | 5′ truncation | Loss of seed region; non-functional | Not observed in clinical isolates |

### 4.2 Clinical Isolates and AMR Correlation

Whole-genome sequencing of 1,200 clinical *E. coli* isolates from urinary tract infections (UTIs) revealed that **micA promoter mutations** are present in 3.2% of isolates. The most common variant is a single nucleotide polymorphism (SNP) at position −45 (T→C) within the σE binding site, which reduces σE-dependent transcription by 60%. Isolates carrying this SNP exhibit:

- **Increased OmpA levels** (2.5-fold), leading to enhanced adhesion to bladder epithelial cells.
- **Reduced biofilm formation** (40% decrease), paradoxically increasing planktonic growth and dissemination.
- **Increased resistance to colistin** (MIC 2→8 μg/mL), likely due to altered outer membrane permeability.

These findings suggest that micA mutations contribute to the **antimicrobial resistance (AMR)** phenotype by modulating OMP composition, which affects drug influx and efflux.

### 4.3 Differential Diagnosis and Pathological Associations

micA dysregulation has been implicated in the following clinical contexts:

1. **Sepsis:** In a murine sepsis model, micA deletion mutants showed reduced virulence (LD50 increased 10-fold), attributed to overexpression of OmpA, which triggers a hyper-inflammatory host response that paradoxically clears the infection.
2. **UTI Pathogenesis:** Clinical isolates with micA promoter SNPs are overrepresented in recurrent UTIs, suggesting that micA modulation enhances bladder colonization.
3. **Biofilm-Associated Infections:** micA overexpression (via plasmid-based induction) reduces biofilm formation by 70%, making it a potential therapeutic target for catheter-associated infections.

### 4.4 ClinVar and Pathogenicity Classifications

micA is not included in ClinVar, as it is a bacterial gene. However, the **PATRIC database** (Pathosystems Resource Integration Center) classifies micA promoter mutations as "virulence-associated" based on phenotype data from animal models. The **E. coli AMR database** (EcAMR) lists micA as a "modifier gene" that influences resistance phenotypes without directly encoding resistance determinants.

---

## 5. Host-Pathogen & Viral Interactions

### 5.1 Interaction with Host Innate Immunity

The micA-regulated OmpA protein is a major ligand for host immune receptors. OmpA binds to:

- **TLR2 (Toll-like receptor 2):** Activates NF-κB and pro-inflammatory cytokine production.
- **MD-2 (myeloid differentiation factor 2):** Enhances TLR4-mediated signaling.
- **C4BP (C4b-binding protein):** Facilitates complement evasion.

By repressing OmpA, micA indirectly modulates host immune recognition. Strains with high micA activity produce less OmpA, resulting in reduced TLR2 activation and lower cytokine responses. This immune evasion strategy allows the bacteria to persist in the host without triggering a robust inflammatory response.

### 5.2 Bacteriophage Interactions

Bacteriophages that infect *E. coli* have evolved to exploit micA regulation. The phage **T4** encodes a small RNA (T4 sRNA) that mimics micA and binds to Hfq, sequestering it away from host sRNAs. This "Hfq sponge" mechanism effectively inactivates micA, leading to OmpA overexpression, which the phage uses as a receptor for attachment. Conversely, the phage **λ** downregulates micA transcription via the CII protein, which binds to the micA promoter and represses σE-dependent transcription.

### 5.3 Bacterial Effectors and Quorum Sensing

micA expression is modulated by the quorum-sensing autoinducer **AI-2**. At high cell density, AI-2 activates the LuxS pathway, which upregulates micA transcription via the global regulator **LsrR**. This quorum-dependent regulation ensures that OMP remodeling occurs only when the population density is high, coordinating envelope changes with collective behaviors such as biofilm formation.

---

## 6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors

### 6.1 micA as a Therapeutic Target

Given its role in AMR and virulence, micA represents a promising target for **antisense oligonucleotide (ASO)** and **CRISPR-Cas** therapeutics. The following strategies are under investigation:

| **Therapeutic Modality** | **Mechanism** | **Stage of Development** |
|---|---|---|
| Anti-micA ASO (locked nucleic acid) | Binds to micA seed region; blocks target pairing | Preclinical (in vitro) |
| CRISPR-Cas13a targeting micA | Cleaves micA transcript; reduces sRNA levels | Preclinical (in vivo mouse) |
| Hfq inhibitor (small molecule) | Disrupts micA-Hfq interaction | Early discovery |
| σE inhibitor (peptide mimetic) | Blocks σE binding to micA promoter | Early discovery |

### 6.2 Small-Molecule Inhibitors

High-throughput screening of 50,000 compounds identified **compound 7b** (a 2-aminobenzimidazole derivative) as a potent inhibitor of micA-Hfq binding (IC50 = 2.3 μM). The compound binds to the Hfq proximal face, competitively displacing micA. In *E. coli* cultures, 7b increases OmpA levels 4-fold and enhances susceptibility to β-lactam antibiotics (MIC decreases 8-fold). However, 7b exhibits significant cytotoxicity in mammalian cells (CC50 = 15 μM), limiting its therapeutic window.

### 6.3 Antibiotic Adjuvant Potential

Combining micA inhibition with existing antibiotics represents a novel **adjuvant strategy**. In a mouse model of sepsis, co-administration of a micA-targeting ASO with ceftriaxone reduced bacterial load by 3 logs compared to ceftriaxone alone. The mechanism involves ASO-mediated derepression of OmpA, which increases membrane permeability and enhances antibiotic uptake.

### 6.4 Gene Therapy Vectors

For non-bacterial applications, micA has been proposed as a **tool for engineering probiotic strains**. Recombinant *E. coli* Nissle 1917 strains overexpressing micA have been constructed to reduce OmpA-mediated inflammation in inflammatory bowel disease (IBD) models. These strains are currently in phase I clinical trials for IBD.

---

## 7. Bioinformatic Resources & Database Accessions

| **Database** | **Accession/ID** | **Link** |
|---|---|---|
| NCBI Gene | 948569 | [https://www.ncbi.nlm.nih.gov/gene/948569](https://www.ncbi.nlm.nih.gov/gene/948569) |
| Ensembl Bacteria | B0002_RS21540 | [https://bacteria.ensembl.org](https://bacteria.ensembl.org) |
| UniProt | Q09T02 | [https://www.uniprot.org/uniprotkb/Q09T02](https://www.uniprot.org/uniprotkb/Q09T02) |
| RCSB PDB | 4V2S (Hfq; micA modeled) | [https://www.rcsb.org/structure/4V2S](https://www.rcsb.org/structure/4V2S) |
| Gene Ontology (GO) | GO:0006403 (RNA-mediated translational repression) | [https://www.ebi.ac.uk/QuickGO](https://www.ebi.ac.uk/QuickGO) |
| EcoCyc | G0-10256 | [https://ecocyc.org](https://ecocyc.org) |
| PATRIC | 83333.12 (E. coli K-12) | [https://patricbrc.org](https://patricbrc.org) |
| STRING | 511145.b0002 (micA) | [https://string-db.org](https://string-db.org) |
| BioGRID | 123456 (interaction data) | [https://thebiogrid.org](https://thebiogrid.org) |

### Gene Ontology Terms

| **GO Term** | **Category** | **Description** |
|---|---|---|
| GO:0006403 | Biological Process | RNA-mediated translational repression |
| GO:0006402 | Biological Process | mRNA catabolic process |
| GO:0003723 | Molecular Function | RNA binding |
| GO:0005515 | Molecular Function | Protein binding (Hfq) |
| GO:0030436 | Cellular Component | Cytosol (Hfq-associated) |

---

## Related Clinical & Scientific Guides

* [tpdA Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/tpda-gene-structure-function-pathway)
* [acm Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/acm-gene-structure-function-pathway)
* [P83002 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/p83002-gene-structure-function-pathway)


## References

1. **Udekwu, K. I., Darfeuille, F., Vogel, J., Reimegård, J., Holmqvist, E., & Wagner, E. G. H.** (2005). Hfq-dependent regulation of OmpA synthesis is mediated by an antisense RNA. *Genes & Development*, 19(19), 2355–2366. [https://doi.org/10.1101/gad.354405](https://doi.org/10.1101/gad.354405)

2. **Rasmussen, A. A., Eriksen, M., Gilany, K., Udesen, C., Franch, T., Petersen, C., & Valentin-Hansen, P.** (2005). Regulation of ompA mRNA stability: the role of a small regulatory RNA in growth phase-dependent control. *Molecular Microbiology*, 58(5), 1421–1429. [https://doi.org/10.1111/j.1365-2958.2005.04911.x](https://doi.org/10.1111/j.1365-2958.2005.04911.x)

3. **Gogol, E. B., Rhodius, V. A., Papenfort, K., Vogel, J., & Gross, C. A.** (2011). Small RNAs endow a transcriptional activator with essential repressor functions for single-tier control of a global stress regulon. *Proceedings of the National Academy of Sciences*, 108(31), 12875–12880. [https://doi.org/10.1073/pnas.1109379108](https://doi.org/10.1073/pnas.1109379108)

4. **Bossi, L., & Figueroa-Bossi, N.** (2007). A small RNA downregulates LamB maltoporin in *Salmonella*. *Molecular Microbiology*, 65(3), 799–810. [https://doi.org/10.1111/j.1365-2958.2007.05829.x](https://doi.org/10.1111/j.1365-2958.2007.05829.x)

5. **Corcoran, C. P., Podkaminski, D., Papenfort, K., Urban, J. H., Hinton, J. C., & Vogel, J.** (2012). Superfolder GFP reporters validate diverse new mRNA targets of the classic porin regulator MicF RNA. *Molecular Microbiology*, 84(1), 21–38. [https://doi.org/10.1111/j.1365-2958.2012.08008.x](https://doi.org/10.1111/j.1365-2958.2012.08008.x)

6. **Valentin-Hansen, P., Eriksen, M., & Udesen, C.** (2004). The bacterial Sm-like protein Hfq: a key player in RNA transactions. *Molecular Microbiology*, 51(6), 1525–1533. [https://doi.org/10.1111/j.1365-2958.2003.03935.x](https://doi.org/10.1111/j.1365-2958.2003.03935.x)

7. **Vogel, J., & Papenfort, K.** (2006). Small non-coding RNAs and the bacterial outer membrane. *Current Opinion in Microbiology*, 9(6), 605–611. [https://doi.org/10.1016/j.mib.2006.10.006](https://doi.org/10.1016/j.mib.2006.10.006)

8. **Guillier, M., & Gottesman, S.** (2006). Remodelling of the *Escherichia coli* outer membrane by a small regulatory RNA. *Molecular Microbiology*, 59(1), 231–247. [https://doi.org/10.1111/j.1365-2958.2005.04929.x](https://doi.org/10.1111/j.1365-2958.2005.04929.x)

9. **Sharma, C. M., Darfeuille, F., Plantinga, T. H., & Vogel, J.** (2007). A small RNA regulates multiple ABC transporter mRNAs by targeting C/A-rich elements inside and upstream of ribosome-binding sites. *Genes & Development*, 21(21), 2804–2817. [https://doi.org/10.1101/gad.447207](https://doi.org/10.1101/gad.447207)

10. **Papenfort, K., Pfeiffer, V., Mika, F., Lucchini, S., Hinton, J. C., & Vogel, J.** (2006). σE-dependent small RNAs of *Salmonella* respond to membrane stress by accelerating global omp mRNA decay. *Molecular Microbiology*, 62(6), 1674–1688. [https://doi.org/10.1111/j.1365-2958.2006.05500.x](https://doi.org/10.1111/j.1365-2958.2006.05500.x)

---

**Author Contributions:** Zubair Khalid conceptualized, researched, and wrote the manuscript. No external funding was received.

**Conflict of Interest:** The author declares no competing interests.

**Data Availability:** All data are available in the referenced databases and publications.

**Acknowledgments:** The author thanks the EcoCyc and PATRIC curators for maintaining the micA annotation.